Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
With self-reported pain, fatigue, sleep disturbance in the last three months and their 'worst' severity rating ≥ 3 (0-10 numeric rating scale) for at least two of the three symptoms
Who have completed their primary cancer treatment (e.g., surgery, radiotherapy, chemotherapy) at least 3 months prior and within 5 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 10th acupuncture treatment, at 6 weeks post-baseline (study completion)
Awards & highlights
Study Summary
This trial will study whether acupuncture is a feasible and acceptable treatment for breast cancer survivors, and will explore changes in biomarkers after the acupuncture intervention.
Who is the study for?
This trial is for English-speaking women who finished primary breast cancer treatment (stages 0-III) at least 3 months ago but within the last 5 years, are on adjuvant endocrine therapy, and suffer from pain, fatigue, or sleep issues with a severity of ≥3. Excluded are those with recent psychiatric hospitalization, bleeding disorders, pregnancy or inability to complete study procedures.Check my eligibility
What is being tested?
The study tests if acupuncture can alleviate psychoneurological symptoms like pain, fatigue, and sleep disturbances in breast cancer survivors. Participants will receive acupuncture treatments twice weekly over five weeks while researchers track changes in biomarkers.See study design
What are the potential side effects?
Acupuncture may cause minor side effects such as slight bleeding or bruising at needle sites, dizziness or fainting during treatment. Most people find it relatively safe with minimal discomfort.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have experienced significant pain, fatigue, or sleep problems in the last three months.
Select...
I finished my main cancer treatment between 3 months and 5 years ago.
Select...
I have been diagnosed with early to mid-stage breast cancer.
Select...
I am currently on hormone therapy for cancer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after 10th acupuncture treatment, at 6 weeks post-baseline (study completion)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 10th acupuncture treatment, at 6 weeks post-baseline (study completion)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
PROMIS Fatigue
PROMIS Pain Interference
PROMIS Sleep Disturbance
Secondary outcome measures
PROMIS Anxiety
PROMIS Depression
Side effects data
From 2013 Phase 1 & 2 trial • 104 Patients • NCT013058112%
Serious unexpected
2%
Pain on needling
100%
80%
60%
40%
20%
0%
Study treatment Arm
Bi-Weekly Acupuncture
Wait List
Trial Design
1Treatment groups
Experimental Treatment
Group I: AcupunctureExperimental Treatment1 Intervention
All subjects will receive active acupuncture. The acupuncture intervention will consist of 10 acupuncture sessions, twice weekly for 5 weeks. There will be at least 1 day in between session.
Find a Location
Who is running the clinical trial?
University of Illinois at ChicagoLead Sponsor
604 Previous Clinical Trials
1,558,929 Total Patients Enrolled
10 Trials studying Breast Cancer
1,342,290 Patients Enrolled for Breast Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have experienced significant pain, fatigue, or sleep problems in the last three months.I am unable to complete study tasks due to physical or mental reasons.I finished my main cancer treatment between 3 months and 5 years ago.I have been diagnosed with early to mid-stage breast cancer.I have been hospitalized for a mental health issue in the last 2 years.I have a condition that affects my blood's ability to clot.I am currently on hormone therapy for cancer.
Research Study Groups:
This trial has the following groups:- Group 1: Acupuncture
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities for volunteers to partake in the current experiment?
"According to the data on clinicaltrials.gov, this medical study is not currently open for recruitment. Initially posted in November 2021 and last updated September 2022, it appears that there are no patients being sought at this time; however, 2603 other trials remain active with enrollment openings."
Answered by AI
Share this study with friends
Copy Link
Messenger